22157.jpg
Testicular Cancer - Global Pipeline Insights, 2022
January 11, 2023 07:43 ET | Research and Markets
Dublin, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The "Testicular Cancer - Pipeline Insights, 2022" clinical trials has been added to ResearchAndMarkets.com's offering.This "Testicular Cancer - Pipeline...
hemoglobinopathies-market-size.jpg
Global Hemoglobinopathies Market Report 2022: Featuring Abbott, Sanofi, Danaher, Pfizer, Merck & More
January 10, 2023 10:18 ET | Research and Markets
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel,...
researchdrivelogo.jpg
Global Biosimilar Market to Gather $83,836.40 Million by 2028, Growing at a CAGR of 24.90% in the 2021-2028 Timeframe [170-Pages] | Issued by Research Dive
January 03, 2023 09:02 ET | Research Dive
New York, USA, Jan. 03, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Research Dive, the global biosimilar market is expected to gather a revenue of $83,836.40 million by...
North American Glycomic Therapeutics Market
North America Glycomic Therapeutics Market Report 2022: Increasing Research and Development Bolsters Sector Growth
December 30, 2022 07:33 ET | Research and Markets
Dublin, Dec. 30, 2022 (GLOBE NEWSWIRE) -- The "North America Glycomic Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - Class, Structures, Indications, Mode of Action"...
22157.jpg
Cancer Immunotherapy Global Market Report 2022: Spike in R&D Efforts for the Creation of Novel Oncology Treatment Bolsters 7.5% Annual Growth
December 29, 2022 06:13 ET | Research and Markets
Dublin, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market by Product, Distribution Channel, Application, End Use, and by Region - Global Forecast to 2022-2033" report has been added...
22157.jpg
2022 TYSABRI (Natalizumab) Report: A Recombinant Humanized IgG4 Monoclonal Antibody Produced in Murine Myeloma Cells - Drug Insight and Market Forecasts to 2032
December 22, 2022 06:03 ET | Research and Markets
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "TYSABRI (Natalizumab), Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering."TYSABRI (Natalizumab),...
22157.jpg
Precision Cancer Therapeutics Market Research Report 2022: Analysis of Abecma, Breyanzi, Carvykti, Kymriah, Tecartus, Yescarta
December 22, 2022 05:43 ET | Research and Markets
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "Precision Cancer Therapeutics, 2022" report has been added to ResearchAndMarkets.com's offering. The analyst has watched the cancer treatment market...
22157.jpg
Leiomyosarcoma Drug Pipeline Research Report 2022: Comprehensive Insights on 18+ Companies and 18+ Pipeline Drugs
December 19, 2022 05:18 ET | Research and Markets
Dublin, Dec. 19, 2022 (GLOBE NEWSWIRE) -- The "Leiomyosarcoma - Pipeline Insight, 2022" clinical trials has been added to ResearchAndMarkets.com's offering.This "Leiomyosarcoma - Pipeline Insight,...
22157.jpg
Sepsis Drug Pipeline Research Report 2022: Comprehensive Insights about 40+ Companies and 40+ Pipeline Drugs
December 15, 2022 08:13 ET | Research and Markets
Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Sepsis - Pipeline Insight, 2022" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about...
Global Therapeutic Monoclonal Antibodies Market
Global Therapeutic Monoclonal Antibodies Market to Reach $1.07 Trillion by 2028 at an 18.6% CAGR
December 15, 2022 07:48 ET | Research and Markets
Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Global Therapeutic Monoclonal Antibodies Market - Analysis By Source, Target, Indication, Route of administration, By Region, By Country: Market...